Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yi Wei
Institutions:
China Academy of Chinese Medical Sciences,
Guang’anmen Hospital
Observed institutions:
Chinese Academy of Sciences,
Changchun Institute of Applied Chemistry,
China Academy of Chinese Medical Sciences,
Guang’anmen Hospital,
State Key Laboratory of Rare Earth Resources Utilization
ORCID:
0009-0003-4825-8836
Observed ORCID:
0009-0003-4825-8836
OpenAlex ID:
A5103774920
Modulation of NLRP3 Inflammasome: Advantages of Chinese Herbal Medicine in Treating Myocardial Ischemia/Reperfusion Injury
2025
·
Yihang Du
, Chenglin Duan
, et al.
·
The American Journal of Chinese Medicine
·
8
Endogenous/exogenous dual stimulation “ROS engineering” amplification combined with autophagy-augmented for efficient ferroptosis therapy
2024
·
Pengye Du
, Pengpeng Lei
, et al.
·
Nano Research
·
2
Abstract 5316: SM2256: A bispecific conditional CD40 and 4-1BB dual agonist for enhanced solid tumor immune response
2024
·
Wenjing Song
, Simin Yang
, et al.
·
Cancer Research
·
1
Abstract 1341: SM2235: A bispecific EGFR x CD16A innate immune cell engager for enhanced treatment of EGFR-expressing solid tumors, regardless of RAS mutation status
2024
·
Huiqin Geng
, Wenjing Song
, et al.
·
Cancer Research
·
1
Clinical outcome of aortic arch sliding aortoplasty for surgical repair of coarctation of the aorta and hypoplastic aortic archin infants
2016
·
Qiang Meng
, Yi Wei
, et al.
·
Chinese Journal of Extracorporeal Circulation
Show more works
View as search
Works count:
5
Citation count:
12
H-index:
2
I10-index:
Year
Topic
Type